Company profile: Carbogen Amcis
1.1 - Company Overview
Company description
- Provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries, including CDMO support for drug substances and drug products, high potency API development and manufacturing, production of cholesterol, lanolin derivatives and vitamin D/D2 analogs, integrated analytical services, and non-GMP manufacturing of starting materials, intermediates, fine and specialty chemicals.
Products and services
- Drug Product CDMO: Architects and fabricates pharmaceutical formulations from design to commercial-scale production, ensuring regulatory compliance throughout development and manufacturing of drug products
- Drug Substance CDMO: Engineers process development and optimization, then produces scalable manufacturing of active pharmaceutical ingredients (APIs) throughout the drug development lifecycle
- High Potency APIs: Develops and produces high potency active pharmaceutical ingredients (APIs) with specialized containment facilities for development and manufacturing of potent compounds
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Carbogen Amcis
Remus Pharmaceuticals
HQ: United States
Website
- Description: Provider of sterile liquid injectables and oral solid forms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remus Pharmaceuticals company profile →
Synchrogenix
HQ: United States
Website
- Description: Provider of strategic regulatory writing and related services for the pharmaceutical and biotech industry, offering regulatory strategy, consulting, and submissions support from preclinical to post-marketing; eCTD publishing and management; medical writing and scientific communications; clinical data transparency, anonymization and redaction; document quality and management; and GlobalSubmit eCTD software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synchrogenix company profile →
Mapi
HQ: France
Website
- Description: Provider of patient-centered research services to the global healthcare industry, serving academia, life science researchers, and the pharmaceutical industry for over 40 years.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mapi company profile →
Heinlein Plastik-Technik
HQ: Germany
Website
- Description: Provider of plastic closures, dosing systems, and application aids for liquid products, including screw caps with various sealing options and dosing/application inserts, tamper-evident and child-resistant closures, measuring cups and spoons with customizable scales, glass and plastic pipette assemblies, and dosing syringes in various volumes and scales.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Heinlein Plastik-Technik company profile →
Jean Brown Research
HQ: United States
Website
- Description: Provider of clinical research site management services, conducting post-operative pain studies for pharmaceutical companies. With 30+ years of experience in pain management protocols, vaccine testing, and phase I-IV studies, JBR operates two facilities near Salt Lake City, Utah and trains staff in patient interaction to deliver accurate, detailed study results using proprietary training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jean Brown Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Carbogen Amcis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Carbogen Amcis
2.2 - Growth funds investing in similar companies to Carbogen Amcis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Carbogen Amcis
4.2 - Public trading comparable groups for Carbogen Amcis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →